Skip to content
Open access

Whole-genome sequencing in mitral valve prolapse: an exploratory study on genes associated with mitral valve prolapse and cardiac arrhythmias

Sep 2026 · medRxiv · 0 citations
Medicine

TL;DR

This targeted WGS study expands the genetic landscape of MVP and/or MAD, identifying several coding and regulatory variants across extracellular matrix, developmental, and electrophysiological pathways.

Read PDF

Similar papers

Open access Oct 2026

Arrhythmogenic mitral valve prolapse and underlying cardiomyopathic substrates: a genetic case-control Study using UK Biobank and NIH all of Us

Arrhythmogenic mitral valve prolapse (aMVP) has been associated with malignant ventricular arrhythmias and sudden cardiac death(1). Whether aMVP represents a distinct genetic entity or reflects phenotypic overlap with underlying cardiomyopathic or inherited arrhythmia substrates remains unclear. To evaluat...

K. Galanti, G. Sharaf Dabbagh, K. Hesse et al. · 0 citations
Open access Oct 2026

Diagnostic yield of inherited cardiac conditions in first-degree relatives of decedents and survivors with isolated valvular heart disease

It is suggested that isolated valvular abnormalities in this context may represent phenotypic markers of a broader inherited cardiac substrate and comprehensive clinical evaluation of first-degree relatives should extend beyond valvular assessment to include screening for cardiomyopathies to optimise diagnostic yield a...

D. Abioye · 0 citations
Open access Oct 2026

Atrial Fibrillation in Valvular Heart Disease

Background Atrial fibrillation (AF) in valvular heart disease (VHD) is generally attributed to pressure or volume overload with atrial remodeling, but the independent contribution of genetic predisposition remains unclear. Objectives The authors evaluated the predictive value of a previously developed AF polygenic risk...

L. Cristin, Janet J. Tang, Lionel Tastet et al. · 0 citations
Review Open access Oct 2026

Genetic variant spectrum in dilated and non-dilated left ventricular cardiomyopathy

The latest European Society of Cardiology (ESC) guidelines on cardiomyopathies introduced non-dilated left ventricular cardiomyopathy (NDLVC) as a distinct clinical phenotype within a phenotype-based classification framework. Despite growing recognition of this entity, data on its genetic architecture and its pot...

T. Barkan, H. Feldman, D. Viskin et al. · 0 citations
Open access Oct 2026

Unveiling the distinctive features of arrhythmic mitral valve prolapse by three-dimensional left ventricular shape modelling and late-gadolinium-enhancement microstructure analysis

Arrhythmic mitral valve prolapse (aMVP) is associated with malignant ventricular arrhythmias (VA) despite the absence of significant mitral regurgitation (MR) or left ventricular (LV) dysfunction. Advances in cardiovascular magnetic resonance (CMR) provided opportunities to implement a-MVP characterization. Howev...

S. Di Maio, F. Deharo, H. Zaidi et al. · 0 citations
Open access Oct 2026

Primary, atrial secondary, and ventricular secondary mitral regurgitation in the general population

While primary mitral valve regurgitation (PMR) results from structural abnormalities of the mitral valve leaflets, secondary mitral valve regurgitation (SMR) arises from either mitral annular dilatation (atrial type, aSMR) or left ventricle remodelling (ventricular type, vSMR) in the absence of intrinsic leaflet diseas...

L. Keil, A. Hapfelmeier, J. Wenzel et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.